Literature DB >> 9690814

Ubiquitin, E6-AP, and their role in p53 inactivation.

M Scheffner1.   

Abstract

Inactivation of the tumor suppressor protein p53 plays a key role in human carcinogenesis. Activation of the growth-suppressive properties of p53 by appropriate stress signals, including genotoxic stress, is generally accompanied by intracellular accumulation of the protein. This suggests that stabilization of the otherwise short-lived protein is an intrinsic feature of p53 activation. The ubiquitin/proteasome system is believed to be a major proteolytic system involved in selective degradation of cell regulatory proteins. In this review, the potential role of the ubiquitin/proteasome system in p53 degradation and possible mechanisms involved in p53 stability regulation are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690814     DOI: 10.1016/s0163-7258(98)00003-5

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  20 in total

1.  Activation of p53 in cervical carcinoma cells by small molecules.

Authors:  S Hietanen; S Lain; E Krausz; C Blattner; D P Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

2.  Gps2, a protein partner for human papillomavirus E6 proteins.

Authors:  Y Y Degenhardt; S J Silverstein
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 3.  Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets.

Authors:  Dingding Shi; Steven R Grossman
Journal:  Cancer Biol Ther       Date:  2010-10-15       Impact factor: 4.742

4.  1H, 15N and 13C assignments of the catalytic domain of E6-associated protein (E6AP).

Authors:  Y S Wu; P J Domaille
Journal:  J Biomol NMR       Date:  2001-11       Impact factor: 2.835

5.  Ubiquitin-fused and/or multiple early genes from cottontail rabbit papillomavirus as DNA vaccines.

Authors:  Sancy A Leachman; Mark Shylankevich; Martin D Slade; Dana Levine; Ranjini K Sundaram; Wei Xiao; Marianne Bryan; Daniel Zelterman; Robert E Tiegelaar; Janet L Brandsma
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  Immunohistochemical expression of ubiquitin and telomerase in cervical cancer.

Authors:  Toro de Méndez Morelva; Llombart Bosch Antonio
Journal:  Virchows Arch       Date:  2009-08-14       Impact factor: 4.064

7.  Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6.

Authors:  S Camus; S Menéndez; C F Cheok; L F Stevenson; S Laín; D P Lane
Journal:  Oncogene       Date:  2007-01-15       Impact factor: 9.867

8.  GRIM-19 disrupts E6/E6AP complex to rescue p53 and induce apoptosis in cervical cancers.

Authors:  Ying Zhou; Ying Wei; Jing Zhu; Qingyuan Wang; Liang Bao; Yang Ma; Yu Chen; Dingqing Feng; Aijin Zhang; Jie Sun; Shreeram C Nallar; Keng Shen; Dhananjaya V Kalvakolanu; Weihua Xiao; Bin Ling
Journal:  PLoS One       Date:  2011-07-12       Impact factor: 3.240

9.  A genomic survey of HECT ubiquitin ligases in eukaryotes reveals independent expansions of the HECT system in several lineages.

Authors:  Xavier Grau-Bové; Arnau Sebé-Pedrós; Iñaki Ruiz-Trillo
Journal:  Genome Biol Evol       Date:  2013       Impact factor: 3.416

10.  A new approach for prediction of tumor sensitivity to targeted drugs based on functional data.

Authors:  Noah Berlow; Lara E Davis; Emma L Cantor; Bernard Séguin; Charles Keller; Ranadip Pal
Journal:  BMC Bioinformatics       Date:  2013-07-29       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.